Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
UCB's Keppra Procurement Resumed in Shanghai After Regulatory Halt
EBR: UCBUCB

UCB’s Keppra Procurement Resumed in Shanghai After Regulatory Halt

HHS Implements Trump's Order for Most-Favored-Nation Drug Pricing

HHS Implements Trump’s Order for Most-Favored-Nation Drug Pricing

China's CDE Announces 94th Batch of Reference Preparations for Generic Evaluation
CDEGQCE testing

China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation

China's County Hospitals Show Improved Medical Service Capability in 2024
NHC (NHFPC)

China’s County Hospitals Show Improved Medical Service Capability in 2024

Show More